ValiRx ValiRx ValiBio ValiPharma
ValiBIO is an oncology diagnostics company founded in July 2007 and jointly supported by ValiRx plc (www.valirx.com), an AIM listed biotechnology company based in London, UK and BIO.be, a Belgian company of the Institut de Pathologie et de Genetique (IPG) which is the largest pathology analysis centre in Belgium. The company is based in laboratories at IPG.
ValiBio
Live Quote
 
 
Our Strategy & Mission Statement Our Technologies Our Products Media & Press Releases Management Team  
Our Mission :.. Our Technologies :.. Our Products :.. Our Team :..
 

 

ValiBIO is developing novel cancer diagnostic products in 3 main areas:

  • NucleosomicsTM blood tests for the early detection of cancer based on the presence of epigenetic alterations to the nucleosomes of blood in cancer patients
  • HypergenomicsTM tissue biopsy tests for the differential, prognostic and personalised medicine diagnostics of cancer based on the detection of epigenetic alterations in chromatin structure – hypersensitive sites
  • HPV diagnostic tests